We are delighted to announce that the ATAC has been awarded the Princess Royal Training Awards standard in 2022 for tackling skills shortages in the sector.

The award celebrates employers in the UK who can prove that their outstanding training and skills development programmes have resulted in exceptional benefits for their business. In the case of Cell & Gene Therapy Catapult this extends to the positive impact ATAC & ATSTN are having on learners and organisations across the wider Advanced Therapy community.

This is such a great testament to all involved, especially the apprentices who never fail to impress, the ATAC and ATSTN industry pioneers – Cell and Gene Therapy Catapult, Oxford Biomedica, Pharmaron Biologics (UK) Ltd, Replimune, Cobra Biologics, A Charles River Company, NHS Blood and Transplant, GSK and Autolus Ltd, and the many other employers who always offer support and dedication to these programmes.

ATAC has now supported over 250 apprentices from 51 organisations since 2018!

The ATSTN Online Training Platform hosts over 700 programmes, with more than 1,400 active users.

Find out more about the Princess Royal Training Awards here  👉 PRTA2022